Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Mercurius Bromatus
Brand Name
Mercurius Bromatus
Generic Name
Mercurius Bromatus
Active Ingredient
MercurousCategory
Non-Standardized Food Allergenic Extract [EPC]
Salt Form
Iodide
Variants
7
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 200 [hp_C]/1 | PELLET | ORAL | 37662-2504 |
| 500 [hp_C]/1 | PELLET | ORAL | 37662-2505 |
| 12 [hp_C]/1 | PELLET | ORAL | 37662-2501 |
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Mercurius Bromatus, you must consult a qualified healthcare professional.
| 30 [hp_C]/1 | PELLET | ORAL | 37662-2502 |
| 6 [hp_C]/1 | PELLET | ORAL | 37662-2500 |
| 1 [hp_M]/1 | PELLET | ORAL | 37662-2506 |
| 100 [hp_C]/1 | PELLET | ORAL | 37662-2503 |
Detailed information about Mercurius Bromatus
Mercurous, specifically Mercurous Iodide, is classified as a Non-Standardized Food Allergenic Extract [EPC]. It is primarily utilized in specialized diagnostic contexts and historical pharmaceutical preparations under strict medical supervision.
Dosage for Mercurous is highly specialized and depends entirely on the clinical application. Because it is a Non-Standardized Food Allergenic Extract, there is no 'standard' daily dose for general health.
For the identification of mercury sensitivity, a small amount of 0.5% to 1.0% Mercurous Iodide in a petrolatum base is applied to the skin (usually the back) using specialized chambers. This is left in place for 48 hours. The 'dose' is effectively the concentration of the chemical in contact with the skin surface.
In homeopathic practice, Mercurius Iodatus Flavus is used in highly diluted forms. Common potencies include 6X or 30C. These preparations are so dilute that they may contain virtually no molecules of the original substance, which is intended to mitigate toxicity while supposedly retaining 'energetic' properties. Clinical evidence for this use is limited.
Mercurous is generally not recommended for use in pediatric populations due to the extreme sensitivity of the developing nervous system and kidneys to mercury. If diagnostic testing is absolutely necessary, it must be performed by a specialist in pediatric allergy or dermatology using the lowest possible concentrations and minimal exposure times.
Mercurous should be avoided in patients with pre-existing renal (kidney) disease. Mercury is a known nephrotoxin (kidney poison). Even the small amounts absorbed during diagnostic testing could potentially exacerbate underlying renal dysfunction.
Patients with hepatic (liver) impairment should be monitored closely. While the liver is not the primary site of mercury toxicity, impaired metabolic function can alter the body's ability to handle heavy metal stress.
Elderly patients often have reduced glomerular filtration rates (GFR). Therefore, the risk of systemic accumulation from any exposure to mercurous compounds is higher. Diagnostic testing should be performed with caution, ensuring the skin is intact to prevent excess absorption.
Mercurous is almost never 'taken' in the traditional sense in modern medicine.
In the context of diagnostic testing, a 'missed dose' would refer to a patch falling off or a patient missing their follow-up appointment to read the test results. If a patch is removed early, the test must usually be restarted. If using a homeopathic preparation, the missed dose should be skipped, and the regular schedule resumed; do not double the dose.
Acute overdose of Mercurous Iodide is a medical emergency. Signs of acute ingestion include:
Emergency Measures: If ingestion is suspected, call 911 or your local poison control center immediately. Treatment involves gastric lavage, the administration of activated charcoal, and the use of chelating agents like Dimercaprol (BAL) or Succimer (DMSA) to bind the mercury and facilitate excretion.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or use this substance without direct medical guidance.
When used as a diagnostic extract, the most common side effects are localized to the site of application. These include:
These effects typically appear 48 to 72 hours after exposure and may persist for several days after the patch is removed.
Mercurous is a heavy metal derivative. While its classification as a Non-Standardized Food Allergenic Extract implies a specific diagnostic utility, it must be handled with the same precautions as any mercurial compound. It is not for general therapeutic use and should never be used on large areas of broken or denuded skin, as this significantly increases the risk of systemic absorption and toxicity.
No FDA black box warnings for Mercurous in its diagnostic extract form. However, clinicians must treat the substance as a potential systemic toxin if handled improperly.
Mercurous must NEVER be used in the following circumstances:
Mercury is a potent developmental toxin. Exposure during pregnancy is associated with 'Congenital Minamata Disease' symptoms, including cerebral palsy-like symptoms, microcephaly (small head size), and severe developmental delays. Even if used topically for diagnostic purposes, the risk of absorption and subsequent placental transfer makes it generally contraindicated during pregnancy. Healthcare providers should opt for alternative diagnostic methods or postpone testing until after delivery.
Inorganic mercury (including mercurous salts) is excreted into human breast milk. While the amounts absorbed from a single diagnostic patch test are likely small, the infant's developing nervous system is uniquely vulnerable to heavy metal interference. The World Health Organization (WHO) recommends minimizing all forms of mercury exposure for lactating women. If testing is essential, the mother may consider 'pumping and discarding' milk for 48-72 hours, although data on the exact clearance time from breast milk is limited.
Mercurous is not approved for general use in children. The pediatric population is at a higher risk for mercury toxicity due to their smaller body mass and ongoing neurological development. Historical exposure in children led to 'Pink Disease' (acrodynia), characterized by irritability, insomnia, and painful, red, peeling skin on the hands and feet. Diagnostic use in children should only be performed in academic or highly specialized centers where the risks can be strictly managed.
Mercurous (as Mercurous Iodide) acts primarily as a hapten in its role as an allergenic extract. A hapten is a small molecule that is not antigenic by itself but becomes so when attached to a larger carrier protein. In the skin, mercurous ions bind to the sulfur atoms in cysteine residues of dermal proteins. This complex is recognized by the immune system as foreign, triggering a T-cell mediated delayed hypersensitivity reaction.
At the cellular level, the mercurous ion (Hg2 2+) can disrupt mitochondrial function. It has a high affinity for thiol groups (-SH) found in enzymes like pyruvate dehydrogenase. By binding to these sites, it inhibits cellular respiration and leads to the production of reactive oxygen species (ROS), which cause membrane lipid peroxidation and cell death.
The pharmacodynamic effect of Mercurous is dose-dependent and time-dependent. In diagnostic testing, the 'onset' of the allergic reaction typically occurs within 24 to 48 hours, peaking at 72 hours. The duration of the localized inflammatory effect can last from 7 to 14 days. There is no known therapeutic 'benefit' in modern pharmacodynamics; the focus is entirely on the diagnostic threshold for hypersensitivity.
Common questions about Mercurius Bromatus
In modern medicine, Mercurous (specifically Mercurous Iodide) is primarily used as a diagnostic tool to identify mercury allergies. It is classified as a Non-Standardized Food Allergenic Extract, meaning it helps doctors determine if a patient has a hypersensitivity to mercury-containing substances found in the environment or diet. Historically, it was used to treat infections like syphilis, but this practice has been discontinued due to the risk of toxicity. Today, you will most likely encounter it in a dermatologist's office as part of a patch test for contact dermatitis. It is not used for general treatment of any common disease.
The most common side effects of Mercurous, when used for skin testing, are localized to the area where it was applied. These include redness, intense itching, and small bumps or blisters, which indicate a positive allergic reaction. Some patients may also experience temporary darkening of the skin at the test site. If the substance is accidentally absorbed into the body, it can cause more serious issues like a metallic taste in the mouth or sore gums. Because it is a heavy metal, any signs of systemic illness should be reported to a doctor immediately. Most localized skin reactions fade within a week or two.
It is strongly advised to avoid alcohol if you are undergoing testing with Mercurous or if you have been exposed to it. Alcohol can put extra stress on the liver and kidneys, which are the organs responsible for processing and clearing toxins from your body. Furthermore, alcohol can worsen the neurological symptoms associated with heavy metal exposure, such as dizziness or tremors. While a single drink may not cause a major interaction during a skin patch test, it is safer to abstain to ensure your body is in the best condition to handle the diagnostic process. Always consult your healthcare provider about your lifestyle habits during medical testing.
No, Mercurous is not considered safe during pregnancy. Mercury is a well-known toxin that can cross the placenta and interfere with the development of the fetal brain and nervous system. Even small amounts used in diagnostic tests carry a risk that is generally considered to outweigh the benefits. If you are pregnant or planning to become pregnant, you must inform your doctor before undergoing any tests involving mercurous compounds. Most physicians will recommend delaying allergy testing until after the baby is born. Protecting the developing fetus from heavy metal exposure is a high clinical priority.
When used for diagnostic allergy testing, Mercurous works over a period of several days. After the patch is applied to your skin, it typically takes 48 hours for the immune system to recognize the substance and mount a visible reaction. A healthcare provider will usually 'read' the test results at the 48-hour mark and again at 72 or 96 hours. This delayed response is characteristic of the Type IV hypersensitivity that Mercurous is meant to detect. If you are using a homeopathic preparation, the 'onset' is claimed to be gradual, but there is no standardized clinical timeline for these effects. For diagnostic purposes, patience is key to an accurate result.
Since Mercurous is typically applied by a healthcare professional for a specific test, you don't 'stop' it in the way you would a daily pill. If you are wearing a diagnostic patch and experience severe burning or pain, you should contact your doctor before removing it. If you are using a homeopathic version, you can stop taking it suddenly without fear of withdrawal symptoms, as mercury does not cause physical dependence. However, the mercury already in your system will take a long time to clear—often several months. If you suspect you have been overexposed, stopping the source is the first step, followed by a medical evaluation. Never restart exposure without professional advice.
If you miss an appointment to have your Mercurous patch test read, you should contact your dermatologist or allergist immediately. The timing of the reading is critical for an accurate diagnosis; if the patch is left on too long or read too late, the results may be invalid. If you are using a homeopathic preparation and miss a dose, simply skip it and take the next one at your regularly scheduled time. Do not take extra to make up for the missed dose, as this only increases the risk of heavy metal accumulation. Consistent monitoring by a professional is the best way to manage any treatment or test involving mercurials.
Mercurous does not cause weight gain in the traditional sense of increasing body fat. However, one of the serious side effects of mercury toxicity is kidney damage, which can lead to 'nephrotic syndrome.' This condition causes the body to retain fluid, leading to significant swelling (edema) in the legs, ankles, and face, which may appear as sudden weight gain. If you notice rapid weight changes or swelling while being treated with or tested for mercury sensitivity, you should seek medical attention immediately. This is a sign of a serious internal reaction rather than a simple metabolic change. Regular kidney function tests can help monitor this risk.
Mercurous can interact dangerously with several other types of medications. It should not be used alongside other nephrotoxic drugs, such as certain antibiotics (aminoglycosides) or heavy-duty painkillers (NSAIDs), because they can combine to cause severe kidney damage. It also interacts with iodine-containing drugs and other mercury-containing products, increasing the risk of toxicity. Because it is a heavy metal, it can interfere with how your body processes many different substances. Always provide your doctor with a full list of your current medications and supplements before undergoing any procedure involving Mercurous. This helps prevent avoidable and potentially permanent organ damage.
Mercurous Iodide is a basic chemical compound and is not 'branded' in the way modern pharmaceutical drugs are. It is available as a generic chemical for laboratory and diagnostic use. In the context of allergy testing, it is often supplied in standardized kits by various medical diagnostic companies. Homeopathic versions are also sold under the generic name 'Mercurius Iodatus Flavus.' However, because of its toxicity, it is not something you can buy over-the-counter for self-use in most regulated markets. Its availability is strictly controlled to ensure it is only used in safe, medically supervised environments.
Other drugs with the same active ingredient (Mercurous)
> Warning: Stop taking Mercurous and call your doctor immediately if you experience any of these.
Prolonged or repeated exposure to Mercurous can lead to chronic mercury poisoning (hydrargyria). This is characterized by cumulative damage to the central nervous system and kidneys. Patients may develop a 'mercurial tremor,' which typically starts in the fingers and spreads to the eyelids and tongue. There is also a risk of permanent renal tubular damage, leading to chronic kidney disease.
No FDA black box warnings currently exist for Mercurous when used as a Non-Standardized Food Allergenic Extract, largely because its use is restricted to controlled diagnostic settings. However, historical and bulk forms of mercury carry severe warnings regarding neurotoxicity and reproductive harm. The EPA and FDA maintain strict guidelines regarding the environmental and pharmaceutical presence of mercury due to its bioaccumulative nature.
Report any unusual symptoms to your healthcare provider. Even localized reactions should be documented to ensure an accurate diagnostic profile.
If a patient has been exposed to significant amounts of Mercurous or shows signs of toxicity, the following monitoring is required:
Standard diagnostic use of Mercurous does not typically interfere with the ability to drive or operate machinery. However, if systemic toxicity occurs, neurological symptoms such as tremors or impaired coordination would make these activities dangerous.
Alcohol consumption should be avoided if there is any concern about mercury toxicity. Alcohol can exacerbate the neurological effects of heavy metals and may put additional strain on the liver and kidneys during the detoxification process.
In diagnostic testing, 'discontinuation' involves removing the patch and thoroughly cleaning the skin. If a patient is using a homeopathic preparation, it should be stopped immediately if any signs of metallic taste, gum soreness, or skin rash develop. There is no 'withdrawal' syndrome associated with stopping mercurous compounds, but the toxic effects may persist long after the substance is discontinued.
> Important: Discuss all your medical conditions with your healthcare provider before starting Mercurous or undergoing testing.
Mercurous exposure can interfere with several laboratory parameters:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. The interaction between heavy metals and modern pharmaceuticals can be unpredictable.
Conditions requiring careful risk-benefit analysis include:
Patients allergic to Mercurous are likely to be cross-sensitive to:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Mercurous or performing diagnostic procedures.
In patients over 65, the primary concern is age-related decline in renal function. Reduced GFR (Glomerular Filtration Rate) means that any mercury absorbed during testing will stay in the systemic circulation for a longer duration. Furthermore, the elderly are more prone to 'mercurial tremors,' which can be mistaken for essential tremor or Parkinson's disease. Clinicians should perform a baseline renal function assessment before using mercurous-containing extracts in this population.
For patients with a GFR below 60 mL/min/1.73m², the use of Mercurous should be avoided. The compound's nephrotoxic potential is well-documented in clinical literature. In the event of accidental exposure, these patients require immediate monitoring of urine output and may require early intervention with hemodialysis, although dialysis is not highly effective at removing inorganic mercury once it has bound to tissue proteins.
While the liver is not the primary target organ for mercurous toxicity, it plays a role in the production of glutathione, the body's primary antioxidant used to neutralize heavy metals. Patients with Child-Pugh Class B or C hepatic impairment may have depleted glutathione stores, making them more susceptible to the oxidative damage caused by mercurous ions.
> Important: Special populations require individualized medical assessment and a cautious approach to any heavy metal exposure.
| Parameter | Value |
|---|---|
| Bioavailability | <10% (Oral), Minimal (Topical) |
| Protein Binding | >95% (Primarily to albumin and hemoglobin) |
| Half-life | 30 - 60 days (Systemic) |
| Tmax | 2 - 4 hours (Systemic absorption) |
| Metabolism | Disproportionation to Hg0 and Hg2+ |
| Excretion | Renal (50%), Fecal (50%) |
Mercurous is classified as a Non-Standardized Food Allergenic Extract [EPC]. It belongs to the therapeutic category of 'Allergenic Extracts' and the chemical category of 'Inorganic Mercurials.' Related substances in this class include Mercuric Chloride and various plant-derived extracts used in diagnostic allergy panels.